Beacon Capital Management, LLC Vaxart, Inc. Transaction History
Beacon Capital Management, LLC
- $599 Million
- Q3 2025
A detailed history of Beacon Capital Management, LLC transactions in Vaxart, Inc. stock. As of the latest transaction made, Beacon Capital Management, LLC holds 60,314 shares of VXRT stock, worth $24,728. This represents 0.0% of its overall portfolio holdings.
Number of Shares
60,314
Previous 60,314
-0.0%
Holding current value
$24,728
Previous $27,000
22.22%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding VXRT
# of Institutions
44Shares Held
6.06MCall Options Held
50.3KPut Options Held
0-
Marshall Wace, LLP London, X01.95MShares$800,7450.0% of portfolio
-
Black Rock Inc. New York, NY1.77MShares$727,4810.0% of portfolio
-
Raymond James Financial Services Advisors, Inc. St. Petersburg, FL188KShares$77,2370.0% of portfolio
-
Xtx Topco LTD London, X094.3KShares$38,6450.0% of portfolio
-
Hbk Sorce Advisory LLC Erie, PA75.1KShares$30,7980.0% of portfolio
About Vaxart, Inc.
- Ticker VXRT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 126,506,000
- Market Cap $51.9M
- Description
- Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...